BANK OF NEW YORK MELLON CORP – West Pharmaceutical Services, Inc. Transaction History
BANK OF NEW YORK MELLON CORP portfolio value:
$428.78M
portfolio value
BANK OF NEW YORK MELLON CORP quarter portfolio value change:
-18.62%
quarter
West Pharmaceutical Services, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +40.49% | 502.18K shares | 53.75M | $246.08 | 1.74M |
| Q2 2022 | share | Increase | +107.77% | 643.33K shares | 129.85M | $302.37 | 1.24M |
| Q1 2022 | share | Increase | +6.90% | 38.55K shares | -16.72M | $410.71 | 596.96K |
| Q4 2021 | share | Decrease | -2.62% | -15.03K shares | 18.44M | $471.34 | 558.40K |
| Q3 2021 | share | Decrease | -21.22% | -154.44K shares | -17.93M | $424.36 | 573.44K |
| Q2 2021 | share | Increase | +15.78% | 99.18K shares | 84.22M | $358.78 | 727.88K |
| Q1 2021 | share | Increase | +1.21% | 7.49K shares | 1.16M | $281.38 | 628.70K |
| Q4 2020 | share | Increase | +1.12% | 6.90K shares | 7.12M | $282.75 | 621.21K |
| Q3 2020 | share | Increase | +0.95% | 5.75K shares | 30.62M | $274.19 | 614.30K |
| Q2 2020 | share | Decrease | -27.28% | -228.29K shares | 10.83M | $226.45 | 608.54K |
| Q1 2020 | share | Decrease | -0.33% | -2.73K shares | 1.19M | $151.62 | 836.83K |
| Q4 2019 | share | Increase | +2.41% | 19.75K shares | 9.94M | $149.55 | 839.57K |
| Q3 2019 | share | Decrease | -1.13% | -9.36K shares | 12.49M | $140.93 | 819.81K |
| Q2 2019 | share | Increase | +0.66% | 5.47K shares | 12.99M | $124.21 | 829.18K |
| Q1 2019 | share | Increase | +0.81% | 6.61K shares | 10.67M | $109.23 | 823.71K |
| Q4 2018 | share | Decrease | -4.36% | -37.20K shares | -25.37M | $97.03 | 817.09K |
| Q3 2018 | share | Decrease | -0.43% | -3.70K shares | 20.28M | $122.05 | 854.30K |
| Q2 2018 | share | Decrease | -0.36% | -3.09K shares | 9.16M | $98.01 | 858.00K |
| Q1 2018 | share | Decrease | -0.30% | -2.60K shares | -9.19M | $87.01 | 861.10K |
| Q4 2017 | share | Decrease | -0.44% | -3.79K shares | 1.71M | $97.11 | 863.70K |
| Q3 2017 | share | Increase | +1.64% | 14.02K shares | 2.83M | $94.59 | 867.50K |
| Q2 2017 | share | Increase | +1.33% | 11.16K shares | 11.92M | $92.75 | 853.48K |
| Q1 2017 | share | Increase | +3.48% | 28.30K shares | -311K | $79.95 | 842.31K |
| Q4 2016 | share | Increase | +1.07% | 8.65K shares | 9.05M | $82.98 | 814.01K |
| Q3 2016 | share | Increase | +1.27% | 10.13K shares | -343K | $72.75 | 805.36K |
| Q2 2016 | share | Decrease | -5.82% | -49.17K shares | 1.80M | $73.98 | 795.23K |
| Q1 2016 | share | Increase | +0.14% | 1.16K shares | 7.75M | $67.47 | 844.40K |